Literature DB >> 16275744

"Phosphatonins" and the regulation of phosphorus homeostasis.

Theresa J Berndt1, Susan Schiavi, Rajiv Kumar.   

Abstract

Phosphate ions are critical for normal bone mineralization, and phosphate plays a vital role in a number of other biological processes such as signal transduction, nucleotide metabolism, and enzyme regulation. The study of rare disorders associated with renal phosphate wasting has resulted in the discovery of a number of proteins [fibroblast growth factor 23 (FGF-23), secreted frizzled related protein 4 (sFRP-4), matrix extracellular phosphoglycoprotein, and FGF 7 (FGF-7)] that decrease renal sodium-dependent phosphate transport in vivo and in vitro. The "phosphatonins," FGF-23 and sFRP-4, also inhibit the synthesis of 1alpha,25-dihydroxyvitamin D, leading to decreased intestinal phosphate absorption and further reduction in phosphate retention by the organism. In this review, we discuss the biological properties of these proteins, alterations in their concentrations in various clinical disorders, and their possible physiological role.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16275744     DOI: 10.1152/ajprenal.00072.2005

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  44 in total

Review 1.  The emergence of phosphate as a specific signaling molecule in bone and other cell types in mammals.

Authors:  Solmaz Khoshniat; Annabelle Bourgine; Marion Julien; Pierre Weiss; Jérôme Guicheux; Laurent Beck
Journal:  Cell Mol Life Sci       Date:  2010-09-17       Impact factor: 9.261

2.  Tumor-Induced Osteomalacia.

Authors:  Rajiv Kumar; Andrew L Folpe; Brian P Mullan
Journal:  Transl Endocrinol Metab       Date:  2015

Review 3.  Novel mechanisms in the regulation of phosphorus homeostasis.

Authors:  Theresa Berndt; Rajiv Kumar
Journal:  Physiology (Bethesda)       Date:  2009-02

Review 4.  FGF23: its role in renal bone disease.

Authors:  Masafumi Fukagawa; Junichiro James Kazama
Journal:  Pediatr Nephrol       Date:  2006-08-24       Impact factor: 3.714

Review 5.  The Causes of Hypo- and Hyperphosphatemia in Humans.

Authors:  Eugénie Koumakis; Catherine Cormier; Christian Roux; Karine Briot
Journal:  Calcif Tissue Int       Date:  2020-04-13       Impact factor: 4.333

6.  Renal phosphate wasting due to tumor-induced osteomalacia: a frequently delayed diagnosis.

Authors:  M Odette Gore; Brian J Welch; Weidong Geng; Wareef Kabbani; Naim M Maalouf; Joseph E Zerwekh; Orson W Moe; Khashayar Sakhaee
Journal:  Kidney Int       Date:  2008-07-30       Impact factor: 10.612

Review 7.  Post-renal transplantation hypophosphatemia.

Authors:  Khashayar Sakhaee
Journal:  Pediatr Nephrol       Date:  2009-07-15       Impact factor: 3.714

8.  Effect of variations in dietary Pi intake on intestinal Pi transporters (NaPi-IIb, PiT-1, and PiT-2) and phosphate-regulating factors (PTH, FGF-23, and MEPE).

Authors:  Tatiana Martins Aniteli; Flávia Ramos de Siqueira; Luciene Machado Dos Reis; Wagner Vasques Dominguez; Elizabeth Maria Costa de Oliveira; Patrícia Castelucci; Rosa Maria Affonso Moysés; Vanda Jorgetti
Journal:  Pflugers Arch       Date:  2018-01-25       Impact factor: 3.657

Review 9.  Phosphate sensing.

Authors:  Rajiv Kumar
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-07       Impact factor: 2.894

10.  Minerals and vitamins and the risk of bladder cancer: results from the New Hampshire Study.

Authors:  Maree T Brinkman; Margaret R Karagas; Michael Scott Zens; Alan Schned; Raoul C Reulen; Maurice P Zeegers
Journal:  Cancer Causes Control       Date:  2009-12-31       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.